February 2024
1. SCHONHERR H, Ayaz P, Taylor AM, Casaletto JB, et al
   Discovery of lirafugratinib (RLY-4008), a highly selective irreversible small-molecule inhibitor of FGFR2.
   Proc Natl Acad Sci U S A. 2024;121:e2317756121.
   

   >> Share

   
   December 2022
2. ZHAO C, Matalonga J, Lancman JJ, Liu L, et al
   Regenerative failure of intrahepatic biliary cells in Alagille syndrome rescued by elevated Jagged/Notch/Sox9 signaling.
   Proc Natl Acad Sci U S A. 2022;119:e2201097119.
   

   >> Share

   
   April 2022
3. CHENG MT, Chen Y, Chen ZP, Liu X, et al
   Structural insights into the activation of autoinhibited human lipid flippase ATP8B1 upon substrate binding.
   Proc Natl Acad Sci U S A. 2022;119:e2118656119.
   

   >> Share

   
   July 2021
4. NISHIO T, Koyama Y, Liu X, Rosenthal SB, et al
   Immunotherapy-based targeting of MSLN(+) activated portal fibroblasts is a strategy for treatment of cholestatic liver fibrosis.
   Proc Natl Acad Sci U S A. 2021;118.
   

   >> Share

   
   March 2021
5. MULLER K, Honcharova-Biletska H, Koppe C, Egger M, et al
   JNK signaling prevents biliary cyst formation through a CASPASE-8-dependent function of RIPK1 during aging.
   Proc Natl Acad Sci U S A. 2021;118.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share